Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| MNTS | Momentus | $8.82 | $3.08 | 53.66% | 40K | $12M | $4.73$167.81 |
| PASG | Passage Bio | $16.11 | $4.42 | 37.81% | 439 | $50M | $5.12$16.70 |
| TXXS | Listed Funds Trust - 21Shares 2x Long Sui ETF | $27.90 | $7.20 | 34.81% | 79.7K | - | $15.33$28.71 |
| AVXX | Tidal Trust II - Defiance Daily Target 2x Long Avav ETF | $11.72 | $2.84 | 31.96% | 2.2K | - | $7.16$24.58 |
| RGC | Regencell Bioscience | $27.04 | $6.50 | 31.65% | 881 | $13B | $0.09$83.60 |
| BKKT | Bakkt | $14.77 | $3.52 | 31.29% | 134.8K | $356M | $6.81$49.79 |
| OKLL | Tidal Trust II - Defiance Daily Target 2x Long Oklo ETF | $25.33 | $5.81 | 29.76% | 25K | - | $16.09$169.96 |
| ACFN | Acorn Energy | $19.27 | $4.05 | 26.61% | 186.9K | $48M | $12.42$33.00 |
| IREG | Themes ETF Trust - Leverage Shares 2x Long Iren Daily ETF | $26.00 | $5.38 | 26.10% | 800 | - | $13.22$26.01 |
| ABAT | American Battery Technology | $4.66 | $0.96 | 25.95% | 13.8K | $606M | $0.86$11.49 |
Related Articles
Featured Article
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Selena Maranjian|Nov 24, 2025
Is the stock likely to keep surging? The answer seems pretty clear.
Bakkt Is Surging. Is the Stock Ready to Explode After Earnings?
Bram Berkowitz|Feb 14, 2022
The stock is up more than 60% over the past week. Is more upside ahead?
3 Stocks to Avoid This Week
Rick Munarriz|Feb 14, 2022
These investments seem pretty vulnerable right now.
Advertisement
Why Is Everyone Talking About Bakkt Holdings Stock?
Leo Sun|Oct 29, 2021
This little fintech company is attracting a lot of attention with some recent partnership deals it made.
The Coronavirus Pandemic Will Delay 2020 IPOs
Joe Tenebruso|Mar 15, 2020
COVID-19 and initial public offerings don’t go well together.
Gene Therapy Biotech Passage Bio IPOs
Brian Orelli, PhD|Feb 28, 2020
The clinical-stage biotech raised $216 million.
